东赢电竞官网:东赢电竞官网

ACADEMY OF INTEGRATIVE MEDICINE SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE.

东赢电竞官网:院长 吕爱平教授

发布者:中西医发布时间:2020-11-17浏览次数:1914


    吕爱平,医学博士,Dr. Kennedy Wong 冠名讲座教授,博士生导师。

    香港浸会大学中医药学院院长、骨与关节疾病转化医学研究所所长。

    香港RGC生物与医学部委员,香港中医药发展委员会委员。

    粤港澳中医药与免疫疾病研究联合实验室主任。

    全国政协参政议政人才库首批特聘专家,第十一届、第十二届全国政协委员。

 

  曾任中国中医科学院中医基础理论研究所所长(1999-2002);

  中医临床基础医学研究所常务副所长(法人代表)(2006-2012);

  江西本草天工科技有限公司(中药固体制剂制造技术国家工程研究中心)董事长(2002-2006);

  国家自然科学基金委员会医学科学部第三、四届专家咨询委员会委员;

  中国中西医结合学会副会长(2007-2014);

  中国中医科学院首席研究员(2007-2017)。

    2001-2002年度卫生部有突出贡献中青年专家称号获得者;

    2008年国家杰出青年科学基金获得者;

    2014年国家质量监督管理总局中国标准创新突出贡献奖获得者,2018年获得香港政府颁发的行政长官公共服务奖状。

 

长期从事中西医结合医学、病证结合研究,从疾病中医证候分类以及与干预效果关联出发,深入探索了基于病证结合的治疗策略和新药研发策略,从理论和运用层面丰富了病证结合理论,做出了显著成绩。已承担国家、省部级课题57项,先后在Nature Medicine、Nature Communication、Biomaterials等国际知名学术刊物上发表学术论文390余篇。主编专著20余部。获得中国和美国专利60余项。

 

Prof. LV Aiping, Dean

 

LV Aiping, M.D., Dr. Kennedy Y.H. Wong Endowed Chair Professor in Chinese Medicine, Doctoral student supervisor;

Dean of the School of Chinese Medicine & Director of Institute for Advancing Translational Medicine in Bone and Joint Diseases, in Hong Kong Baptist University;

Member of the Chinese Medicine Development Committee in Hong Kong & Member of Biology and Medicine Panel of the Research Grants Council in Hong Kong; Director of Guangdong-Hong Kong-Macao Joint Laboratory of Traditional Chinese Medicine and Immunological Disease Research; Member of the 11th and 12th National Committee of The Chinese People's Political Consultative Conference.

 

(1999-2002) Director of the Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medicine Science;

(2006-2012) Executive Deputy Director of the Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Science (legal representative);

(2002-2006) Chairman of Jiangxi Herbfine Hi-tech Co.,Ltd. (National Engineering Research Center for TCM Solid Dosage Manufacturing Technology);

Member of the Third and Fourth Advisory Committee of the Department of Health Sciences of National Natural Science Foundation of China;

(2007-2014) Vice President of Chinese Association of Integrative Medicine;

(2007-2017) Chief Scientist of Chinese Academy of Chinese Medical Sciences.

(2001-2002) Winner of the title “Young and Middle-aged Experts with Special Achievements and Contributions” conferred byMinistry of Health;

(2008) Winner of the National Science Fund for Distinguished Young Scholars;

(2014) Winner of the Outstanding Contribution Award for Standard Innovation of China conferred by the State Administration for Market Regulation and Standardization Administration of The People’s Republic of China,

(2018) Chief Executive's Commendation for Government/Public Service awarded by the Government of the Hong Kong Special Administrative Region.

 

Prof. LV has been engaged in the researches on integrated Chinese and Western medicine and disease-syndrome combination for a long time. Considering classification of diseases and syndromes in TCM and intervention effects, he has deeply explored treatment strategies and R&D strategies for new drugs based on disease-syndrome combination, theoretically and practically making significant achievements. He was granted 57 projects from national and provincial foundations, has published more than 20 monographs as an editor-in-chief, and over 390 articles in internationally renowned journals such as Nature Medicine, Nature Communication, Biomaterials, etc. Besides, he has more than 60 patents granted in China and the United States.